Related Experiment Video
Updated: Feb 3, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Loss of GINS2 inhibits cell proliferation and tumorigenesis in human gliomas
Yun-Long Shen1, He-Zhen Li1, Yan-Wei Hu2
1Department of Neurosurgery, The Fifth Affiliated Hospital, South Medical University, Guangzhou, China.
Aims:
In this study, we examined the expression of GINS2 in glioma and determined its role in glioma development.
Methods:
The protein expression of GINS2 was assessed in 120 human glioma samples via immunohistochemistry. Then, we suppressed the expression of GINS2 in glioma cell strains U87 and U251 using a short hairpin RNA lentiviral vector. In addition, RNA sequencing and bioinformatics analysis were performed on glioma cells before and after GINS2 knockdown. Subsequent co-immunoprecipitation and western blot experiments indicated possible downstream regulatory molecules.
Results:
The present results showed that GINS2 can accelerate the growth of glioma cells, whereas the suppression of GINS2 expression decreased the proliferation and tumorigenicity of glioma cells. Mechanism research experiments proved that GINS2 can block the cell cycle by regulating certain downstream molecules, such as MCM2, ATM, and CHEK2.
Conclusion:
GINS2 is closely related to the occurrence and development of glioma, and is likely to become a prognostic marker for glioma patients, as well as a potential therapeutic target in the treatment of glioma.
Insights
GINS2 accelerates glioma growth, but suppressing it reduces tumor cell proliferation and tumorigenicity. GINS2 may be a therapeutic target and prognostic marker for glioma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioma is a primary brain tumor with significant mortality.
- Understanding the molecular mechanisms driving glioma development is crucial for effective treatment.
Purpose of the Study:
- To investigate the expression of Ginsenoside Recognition Protein 2 (GINS2) in glioma.
- To determine the role of GINS2 in glioma development and progression.
Main Methods:
- Immunohistochemistry was used to assess GINS2 protein expression in 120 human glioma samples.
- GINS2 expression was suppressed in U87 and U251 glioma cell lines using lentiviral vectors.
- RNA sequencing, bioinformatics analysis, co-immunoprecipitation, and western blot were performed to identify downstream targets.
Main Results:
- GINS2 expression was found to accelerate glioma cell growth, proliferation, and tumorigenicity.
- Suppression of GINS2 led to decreased glioma cell proliferation and tumorigenicity.
- GINS2 was shown to block the cell cycle by regulating downstream molecules including MCM2, ATM, and CHEK2.
Conclusions:
- GINS2 plays a significant role in the occurrence and development of glioma.
- GINS2 is a potential prognostic marker for glioma patients.
- GINS2 represents a potential therapeutic target for glioma treatment.
Related Concept Videos
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Line Loss
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
Abnormal Proliferation
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Energy Losses in Transformers
There are four main reasons for energy losses in transformers.
The first cause can be the high resistance of the...

